Attenuation of lung inflammation and fibrosis in interferon-γ-deficient mice after intratracheal bleomycin

American Journal of Respiratory Cell and Molecular Biology

Volumn 24, Issue 5, 2001, Pages 545-555

  Chen, Edward S ^a   Greenlee, Brian M ^a   Wills Karp, Marsha ^a   Moller, David R ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0035027015     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.24.5.4064     Document Type: Article

References (45)

1. 1. Okamoto, T., T. Amano, T. Wada, M. Harada, and T. Tanaka. 1970. Experimental pulmonary fibrosis induced by bleomycin [Japanese]. Igaku to Seibutsugaku - Medicine & Biology 80:299-301.
2. 2. Adamson, I. Y., and D. H. Bowden. 1974. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77:185-197.
3. 3. Raisfeld, I. H. 1979. Bleomycin-induced pulmonary toxicity: a model for the study of pulmonary fibrosis. In Bleomycin: Chemical, Biochemical and Biological Aspects. S. M. Hecht, editor. Springer-Verlag, New York. 324-335.
4. 4. Schrier, D. J., R. G. Kunkel, and S. H. Phan. 1983. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am. Rev. Respir. Dis. 127:63-66.
5. 5. Haston, C. K., C. I. Amos, T. M. King, and E. L. Travis. 1996. Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Res. 56:2596-2601.
6. 6. Haston, C. K., and E. L. Travis. 1997. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res. 57: 5286-5291.
7. 7. Schrier, D. J., and S. H. Phan. 1984. Modulation of bleomycin-induced pulmonary fibrosis in the BALB/c mouse by cyclophosphamide-sensitive T cells. Am. J. Patholol. 116:270-278.
8. 8. Sharma, S. K., J. A. MacLean, C. Pinto, and R. L. Kradin. 1996. The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury. Am. J. Respir. Crit. Care Med. 154:193-200.
9. 9. Lossos, I. S., R. Or, R. H. Goldstein, M. W. Conner, and R. Breuer. 1996. Amelioration of bleomycin-induced pulmonary injury by cyclosporin A. Exp. Lung Res. 22:337-349.
10. 10. Zhu, J., D. A. Cohen, S. N. Goud, and A. M. Kaplan. 1996. Contribution of T lymphocytes to the development of bleomycin-induced pulmonary fibrosis. Ann. N. Y. Acad. Sci. 796:194-202.
11. 11. Schrier, D. J., S. H. Phan, and B. M. McGarry. 1983. The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis: a biochemical evaluation. Am. Rev. Respir. Dis. 127:614-617.
12. 12. Szapiel, S. V., N. A. Elson, J. D. Fulmer, G. W. Hunninghake, and R. G. Crystal. 1979. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am. Rev. Respir. Dis. 120:893-899.
13. 13. Helene, M., V. Lake-Bullock, J. Zhu, H. Hao, D. A. Cohen, and A. M. Kaplan. 1999. T cell independence of bleomycin-induced pulmonary fibrosis. J. Leukoc. Biol. 65:187-195.
14. 14. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675-1684.
15. 15. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742.
16. 16. Gavett, S. H., D. J. O'Hearn, X. Li, S. K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1527-1536.
17. 17. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biol. 162:156-194.
18. 18. Moller, D. R., M. Wysocka, B. M. Greenlee, X. Ma, L. Wahl, G. Trinchieri, and C. L. Karp. 1997. Inhibition of human interleukin-12 production by pentoxifylline. Immunology 91:197-203.
19. 19. Huszar, G., J. Maiocco, and F. Naftolin. 1980. Monitoring of collagen and collagen fragments in chromatography of protein mixtures. Anal. Biochem. 105:424-429.
20. 20. Gharaee-Kermani, M., and S. H. Phan. 1997. Lung interleukin-5 expression in murine bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 16:438-447.
21. 21. Trinchieri, G. 1998. Proinflammatory and immunoregulatory functions of interleukin-12. Int. Rev. Immunol. 16:365-396.
22. 22. Nathan, C. F., T. J. Prendergast, M. E. Wiebe, E. R. Stanley, E. Platzer, H. G. Remold, K. Welte, B. Y. Rubin, and H. W. Murray. 1984. Activation of human macrophages: comparison of other cytokines with interferon-gamma. J. Exp. Med. 160:600-605.
23. 23. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655-663.
24. 24. Ortiz, L. A., J. Lasky, R. F. Hamilton, Jr., A. Holian, G. W. Hoyle. W. Banks, J. J. Peschon, A. R. Brody, G. Lungarella, and M. Friedman. 1998. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp. Lung Res. 24:721-743.
25. 25. Kilinc, C., O. Ozcan, E. Karaoz, K. Sunguroglu, T. Kutluay, and L. Karaca. 1993. Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies. J. Basic Clin. Physiol. Pharmacol. 4:249-269.
26. 26. Nici, L., A. Santos-Moore, C. Kuhn, and P. Calabresi. 1998. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine. Cancer 83:2008-2014.
27. 27. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306-4310.
28. 28. Salkowski, C. A., G. Detore, R. McNally, N. van Rooljen, and S. N. Vogel. 1997. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. J. Immunol. 158:905-912.
29. 29. Davis, G. S., L. M. Pfeiffer, and D. R. Hemenway. 1999. Expansion of interferon-gamma-producing lung lymphocytes in mouse silicosis. Am. J. Respir. Cell Mol. Biol. 20:813-824.
30. 30. Jimenez, S. A., B. Freundlich, and J. Rosenbloom. 1984. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J. Clin. Invest. 74:1112-1116.
31. 31. Gurujeyalakshmi, G., and S. N. Giri. 1995. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp. Lung Res. 21:791-808.
32. 32. Wynn, T. A., I. Eltoum, A. W. Cheever, F. A. Lewis, W. C. Gause, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1430-1440.
33. 33. Chensue, S. W., K. S. Warmington, J. Ruth, P. M. Lincoln, and S. L. Kunkel, 1994. Cross-regulatory role of interferon-gamma (IFN-gamma), IL-4 and IL-10 in schistosome egg granuloma formation: in vivo regulation of Th activity and inflammation. Clin. Exp. Immunol. 98:395-400.
34. 34. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594-596.
35. 35. Giri, S. N., D. M. Hyde, and B. J. Marafino, Jr. 1986. Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice. Biochem. Med. Metabol. Biol. 36:194-197.
36. 36. Hyde, D. M., and S. N. Giri. 1990. Polyinosinic-polycytidylic acid, an interferon inducer, ameliorates bleomycin-induced lung fibrosis in mice. Exp. Lung Res. 16:533-546.
37. 37. Baecher-Allan, C. M., and R. K. Barth. 1993. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Reg. Immunol. 5:207-217.
38. 38. Izbicki, G., R. Or, T. G. Christensen, M. J. Segel, A. Fine, R. H. Goldstein, and R. Breuer. 1999. Bleomycin-induced lung fibrosis is not IL-4 dependent. Am. J. Respir. Crit. Care Med. 159:A929. (Abstr.)
39. 39. Moller, D. R., J. D. Forman, M. C. Liu, P. W. Noble, B. M. Greenlee, P. Vyas, D. A. Holden, J. M. Forrester, A. Lazarus, M. Wysocka, G. Trinchieri, and C. Karp. 1996. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J. Immunol. 156:4952-4960.
40. 40. Tinkle, S. S., L. A. Kittle, B. A. Schumacher, and L. S. Newman. 1997. Beryllium induces IL-2 and IFN-gamma in berylliosis. J. Immunol. 158:518-526.
41. 41. Gudmundsson, G., and G. W. Hunninghake. 1997. Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J. Clin. Invest. 99:2386-2390.
42. 42. Yamasaki, H., M. Ando, W. Brazer, D. M. Center, and W. W. Cruikshank. 1999. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. J. Immunol. 163:3516-3523.
43. 43. Moller, D. R. 1999. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 16:24-31.
44. 44. Panitch, H. S., R. L. Hirsch, A. S. Haley, and K. P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1:893-895.
45. 45. Ziesche, R., E. Hofbauer, K. Wittmann, V. Petkov, and L. H. Block. 1999. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 341:1264-1269.